Hbk Sorce Advisory LLC Vascular Biogenics Ltd. Transaction History

Hbk Sorce Advisory LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$0.15 - $0.27 $3,086 - $5,555	-20,575 Reduced 50.0%	20,575 $4,000
Q4 2022 Feb 09, 2023	BUY	$0.11 - $0.16 $2,106 - $3,064	19,150 Added 87.05%	41,150 $5,000
Q2 2022 Aug 15, 2022	SELL	$1.22 - $1.95 $396 - $633	-325 Reduced 1.46%	22,000 $35,000
Q1 2022 May 13, 2022	BUY	$1.15 - $1.97 $258 - $443	225 Added 1.02%	22,325 $38,000
Q3 2021 Nov 15, 2021	BUY	$1.94 - $2.55 $194 - $254	100 Added 0.45%	22,100 $45,000
Q1 2021 May 14, 2021	BUY	$1.79 - $2.91 $39,380 - $64,020	22,000 New	22,000 $44,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Hbk Sorce Advisory LLC with notifications on news.